Christine Dolan - Apr 30, 2024 Form 4 Insider Report for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)

Role
Executive Vice President & General Manager, Cygnus Technologies
Signature
/s/ Kurt Oreshack, by power of attorney for Christine Dolan
Stock symbol
MRVI
Transactions as of
Apr 30, 2024
Transactions value $
$2,753
Form type
4
Date filed
5/2/2024, 06:46 PM
Previous filing
Mar 18, 2024
Next filing
Nov 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRVI Class A Common Stock Award $2.75K +483 +0.19% $5.70 258K Apr 30, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 483 shares of Class A Common Stock was exempt pursuant to Rule 16b-3.

Remarks:

Executive Vice President & General Manager, Cygnus Technologies